Abstract:PURPOSE: To compare long-term outcomes of full-bed deep lamellar keratoplasty (DLK) with penetrating keratoplasty (PK) for treating corneal leucoma caused by herpes simplex keratitis (HSK).DESIGN: Retrospective, comparative, interventional case series.METHODS: SETTING: Institutional. PATIENTS: Inclusion criteria were patients with corneal scarring induced exclusively by HSK who underwent primary graft of full-bed DLK or PK and completed a minimum of 12 months postoperative follow-up. There was no significant difference of corneal scarring and vascularization between the 2 groups before surgery. Choosing PK or full-bed DLK depended on the patient's own willingness, except those patients with a preoperative endothelial cell count of less than 700 cells/mm(2) or whose endothelial cell count was undetectable were encouraged to undergo only PK. Exclusion criteria were patients with a past history of corneal perforation, nonprimary graft, non-HSK-related corneal scars, and failure to complete a minimum of 12 months of postoperative follow-up. Fifty-eight eyes of 58 patients in the full-bed DLK group and 63 eyes of 63 patients in the PK group met the inclusion criteria. MAIN OUTCOME MEASURES: Postoperative managements, recurrence of HSK, graft rejection, graft survival rate, visual acuity, and corneal endothelial density.RESULTS: The mean postoperative follow-up duration was 45.8 +/- 30.9 months in the full-bed DLK group and 47.9 +/- 27.2 months in the PK group (P = .70). As compared with the PK group, the full-bed DLK group experienced earlier suture removal (P = .01), needed fewer postoperative visits (P < .001), and had a higher proportion of eyes with full withdrawal of oral acyclovir (P < .001) and topical corticosteroid (P < .001). There were a total of 21 episodes of recurrent HSK in the PK group, more frequent than the 7 episodes in the full-bed DLK group, among which recurrent epithelial keratitis amounted to 13 episodes in the PK group, remarkably more frequent than the 1 episode in the full-bed DLK group. Twenty-six eyes (41.3%) encountered rejection episodes in the PK group, but no rejection episode was found in the full-bed DLK group (P < .001). In 14 eyes in the PK group, graft failure developed because of graft rejection, recurrence of HSK, or both, whereas only in 1 eye in the full-bed DLK group did graft failure develop because of recurrence of HSK (P = .001). The clear graft survival rate in the full-bed DLK group was significantly higher than that in the PK group (P = .01). Corneal endothelial cell density was stable from 1 month through 5 years in the full-bed DLK group, but 51.3% cell loss was found in the PK group at 5 years after surgery. At the last visit, 66.1% of eyes with full-bed DLK grafts and 50.9% of eyes with PK grafts achieved a best-correct visual acuity of 0.5 or better (P = .10).CONCLUSIONS: Advantages of full-bed DLK over PK are no allograft rejection, longer graft survival, earlier drug withdrawal of topical steroid and oral acyclovir, less recurrence of HSK, and fewer follow-up visits. Full-bed DLK is preferable for treating HSK-induced corneal scarring with relatively healthy endothelium and with no history of perforation. (Am J Ophthalmol 2012;153:291-299. (C) 2012 by Elsevier Inc. All rights reserved.)

Bioengineering Corneal Transplantation for Treatment of Herpes Simplex Keratitis Complicated Corneal Leukoplakia

Short‐term Results of Acellular Porcine Corneal Stroma Keratoplasty for Herpes Simplex Keratitis

Clinical study of modified amniotic membrane transplantation combined with corneal contact lens and immunemodulators in the treatment of recrudesced epithelial herpes simplex keratitis

Combined Penetrating Keratoplasty with Keratolimbal Allograft Transplantation in the Treatment of Severe Corneal Burns

Clinical consequences of herpes simplex virus DNA in donor corneas: Different prognosis and management of endothelial keratoplasty and deep anterior lamellar keratoplasty

3D bioprinting for artificial cornea: Challenges and perspectives.

Outcomes of Corneal Transplantation for Herpetic Keratitis: A Narrative Review

Comprehensive evaluation of decellularized porcine corneal after clinical transplantation

Preparation and Evaluation of Bacterial Nanocellulose/Hyaluronic Acid Composite Artificial Cornea for Application of Corneal Transplantation

Long-term Comparison of Full-Bed Deep Lamellar Keratoplasty with Penetrating Keratoplasty in Treating Corneal Leucoma Caused by Herpes Simplex Keratitis

Fabrication of bioengineered corneal endothelial grafts using an allogeneic cornea-derived matrix

Potential of an Amphiphilic Artificial Corneal Endothelial Layer as a Replacement Option for Damaged Corneal Endothelium

Meganuclease targeting HSV-1 protects against herpetic keratitis: Application to corneal transplants

Biomechanical Evaluation of Decellularized and Crosslinked Corneal Implants Manufactured From Porcine Corneas as a Treatment Option for Advanced Keratoconus

Preliminary Studies of Constructing a Tissue-Engineered Lamellar Corneal Graft by Culturing Mesenchymal Stem Cells Onto Decellularized Corneal Matrix.

Development of a novel bioartificial cornea using 3D bioprinting based on electrospun micro-nanofibrous decellularized extracellular matrix

Herpes simplex virus linear endotheliitis in a post-keratoplasty patient: A case report

Ethics Investigation on Heterogenous Cornea Transplant

The treatment of herpes simplex virus necrotizing stromal keratitis

Preclinical evaluation of the safety and effectiveness of a new bioartificial cornea

[ARTIFICIAL CORNEA: FROM THE BEGINNING TO THE FUTURE]